11. Juli 2017

ASCO-Highlights in immunotherapy

Patients with advanced lung cancer, head-and-neck-cancer and melanoma benefit from treatments with immune checkpoint inhibitors nivolumab, pembrolizumab, atezolizumab and ipilimumab.

Cancer immunotherapy research concept cancer gene therapy with test tubes and pipette

Um den Inhalt zu sehen, müssen Sie sich einloggen oder registrieren.